Showing results (971-980 of 1,194) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|August 4, 2020
Designing historical control studies with survival endpoints using exact statistical inferenceGang HanPharmaceutical Statistics|March 30, 2021
Progression-free survival in oncological clinical studies: Assessment time bias and methods for its correctionRobert Miltenberger, Heiko Götte, Armin Schüler, et al.Pharmaceutical Statistics|February 18, 2015
Threshold-free estimation of functional antibody titers of a group B streptococcus opsonophagocytic killing assayLuca Moraschini, Irene Passalacqua, Monica Fabbrini, et al.Pharmaceutical Statistics|May 23, 2023
Adaptively leveraging external data with robust meta-analytical-predictive prior using empirical BayesHongtao Zhang, Yueqi Shen, Judy Li, et al.Pharmaceutical Statistics|May 10, 2023
Stability analysis using mixed models: A critique of tolerance interval methods and a probabilistic solutionStan Altan, Paul Faya, Adam P Rauk, et al.Pharmaceutical Statistics|April 14, 2015
Advantages of a wholly Bayesian approach to assessing efficacy in early drug development: a case studyRosalind J Walley, Claire L Smith, Jeremy D Gale, et al.Pharmaceutical Statistics|June 14, 2012
Testing bioequivalence for multiple formulations with power and sample size calculationsCheng Zheng, Jixian Wang, Lihui ZhaoPharmaceutical Statistics|May 17, 2012
Impact of safety monitoring on error probabilities of binary efficacy outcome analyses in large phase III group sequential trialsYanqiu Weng, Wenle Zhao, Yuko PaleschPharmaceutical Statistics|September 21, 2011
The draft FDA guideline on non-inferiority clinical trials: a critical review from European pharmaceutical industry statisticiansBernhard Huitfeldt, Jürgen Hummel, Pharmaceutical Statistics|September 30, 2011
Modeling data with structural and temporal correlation using lower level and higher level multilevel modelsGareth James, Yinghui Zhou, Sam MillerPageof 120